ImmPACT-Bio
Company description
See translation
ImmPACT-Bio is developing a strategy to differentiate cancerous from noncancerous tissues in order to improve the safety of chimeric antigen receptor T-cell (CAR-T) therapy. The company's product is designed to assure tumor specificity by inducing cytoto...
HS code: {{pas.hsCode | limitTo: 23}}
Commercial information
Affiliations:
People in this company (1)
Contact this company through Start-Up Nation Central
To get in touch with the ConnectAmericas support team, please send an e-mail with your request to soporte@connectamericas.com and we will get back to you briefly.
Follow Us